TerrAscend (TSNDF) EBIT (QoQ) (2021 - 2026)
TerrAscend (TSNDF) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.42 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.71 Bn | 40.06 Bn | 2.15 Bn |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.41 Bn | 683.80 Mn |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | TerrAscend | 197.99 Mn | 155.88 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.14% |
| Mar 31, 2026 | 50.31% |
| Dec 31, 2025 | -31.20% |
| Sep 30, 2025 | 1.55% |
| Jun 30, 2025 | -10.39% |
| Mar 31, 2025 | 4.92% |
| Dec 31, 2024 | 60.86% |
| Sep 30, 2024 | -31.81% |
| Jun 30, 2024 | 75.26% |
| Mar 31, 2024 | 28.85% |
| Dec 31, 2023 | -73.42% |
| Sep 30, 2023 | 406.60% |
| Jun 30, 2023 | -8.09% |
| Mar 31, 2023 | -72.28% |
| Dec 31, 2022 | 104.16% |
| Sep 30, 2022 | -2,756.90% |
| Jun 30, 2022 | -44.89% |
| Mar 31, 2022 | -194.92% |
| Dec 31, 2021 | 574.69% |
| Sep 30, 2021 | -114.46% |